Recently it was reported that male STS deletion carriers show an increased incidence of sinus bradycardia, atrial fibrillation (AF) and atrial flutter (10.5% versus 2.7% in male controls), possibly by affecting circulating dehydroepiandrosterone sulfate levels [2, 3]. Here, STS is linked to atrial fibrillation.